Umb Bank, N.A. Gilead Sciences, Inc. Transaction History

Umb Bank, N.A.

$5.99 Billion
Q2 2024

A detailed history of Umb Bank, N.A. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Umb Bank, N.A. holds 116,318 shares of GILD stock, worth $9.75 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

116,318

Previous 117,936 1.37%

Holding current value

$9.75 Million

Previous $8.64 Million 7.62%

% of portfolio

0.13%

Previous 0.14%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$63.15 - $72.88 $102,176 - $117,919	-1,618 Reduced 1.37%	116,318 $7.98 Million
Q1 2024 Apr 26, 2024	SELL	$71.58 - $87.29 $584,307 - $712,548	-8,163 Reduced 6.47%	117,936 $8.64 Million
Q4 2023 Jan 23, 2024	SELL	$73.27 - $83.09 $760,762 - $862,723	-10,383 Reduced 7.61%	126,099 $10.2 Million
Q3 2023 Oct 18, 2023	SELL	$73.94 - $80.67 $4.7 Million - $5.12 Million	-63,505 Reduced 31.75%	136,482 $10.2 Million
Q2 2023 Jul 25, 2023	BUY	$76.01 - $86.7 $1.33 Million - $1.51 Million	17,471 Added 9.57%	199,987 $15.4 Million
Q1 2023 Apr 11, 2023	BUY	$77.31 - $88.08 $5.37 Million - $6.12 Million	69,488 Added 61.48%	182,516 $15.1 Million
Q4 2022 Jan 10, 2023	BUY	$62.32 - $89.47 $5.83 Million - $8.37 Million	93,537 Added 479.9%	113,028 $9.7 Million
Q3 2022 Oct 13, 2022	SELL	$59.54 - $68.01 $848,325 - $969,006	-14,248 Reduced 42.23%	19,491 $1.2 Million
Q2 2022 Jul 20, 2022	SELL	$57.72 - $65.01 $183,895 - $207,121	-3,186 Reduced 8.63%	33,739 $2.09 Million
Q1 2022 Apr 22, 2022	SELL	$57.92 - $72.58 $14,306 - $17,927	-247 Reduced 0.66%	36,925 $2.2 Million
Q4 2021 Feb 09, 2022	BUY	$64.88 - $73.64 $1.46 Million - $1.66 Million	22,530 Added 153.87%	37,172 $2.7 Million
Q2 2021 Jul 26, 2021	BUY	$63.47 - $69.35 $24,880 - $27,185	392 Added 2.75%	14,642 $1.01 Million
Q1 2021 Apr 15, 2021	BUY	$60.0 - $68.46 $100,800 - $115,012	1,680 Added 13.37%	14,250 $921,000
Q4 2020 Feb 04, 2021	SELL	$56.65 - $64.55 $4,815 - $5,486	-85 Reduced 0.67%	12,570 $732,000
Q2 2020 Jul 16, 2020	SELL	$72.34 - $84.0 $256,589 - $297,948	-3,547 Reduced 21.89%	12,655 $974,000
Q1 2020 May 26, 2020	SELL	$62.63 - $80.22 $140,980 - $180,575	-2,251 Reduced 12.2%	16,202 $1.21 Million
Q4 2019 Jan 31, 2020	SELL	$61.62 - $67.78 $123,178 - $135,492	-1,999 Reduced 9.77%	18,453 $1.2 Million
Q3 2019 Oct 30, 2019	SELL	$62.51 - $69.0 $76,762 - $84,732	-1,228 Reduced 5.66%	20,452 $1.3 Million
Q2 2019 Jul 30, 2019	SELL	$61.87 - $69.38 $86,123 - $96,576	-1,392 Reduced 6.03%	21,680 $1.46 Million
Q1 2019 Apr 30, 2019	SELL	$62.53 - $70.05 $934,448 - $1.05 Million	-14,944 Reduced 39.31%	23,072 $1.5 Million
Q4 2018 Jan 24, 2019	BUY	$60.54 - $79.0 $81,002 - $105,702	1,338 Added 3.65%	38,016 $2.38 Million
Q3 2018 Oct 22, 2018	SELL	$71.28 - $78.92 $931,558 - $1.03 Million	-13,069 Reduced 26.27%	36,678 $2.83 Million
Q2 2018 Jul 31, 2018	SELL	$64.88 - $75.68 $4.53 Million - $5.28 Million	-69,794 Reduced 58.38%	49,747 $3.52 Million
Q1 2018 Apr 25, 2018	BUY	$72.84 - $88.8 $218,301 - $266,133	2,997 Added 2.57%	119,541 $9.01 Million
Q4 2017 Jan 22, 2018	BUY	$71.15 - $83.52 $200,998 - $235,944	2,825 Added 2.48%	116,544 $8.35 Million
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $8.2 Million - $9.72 Million	113,719	113,719 $9.21 Million

Others Institutions Holding GILD

# of Institutions

1,879

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $105B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Umb Bank, N.A., based on Form 13F filings with the SEC.

News

Stay updated on Umb Bank, N.A. with notifications on news.

Account